Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People
Clinical trial NCT05541861 · COMPLETED
Trial details
- NCT number
- NCT05541861
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-08
- Primary completion
- 2024-11-22
- Enrollment
- 383
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.